EClinicalMedicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2022-06-07 HONGGE

第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然

617 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2022-08-10 ms7000001962210336

请问submitted to journal一般多久啊，我都五天了还是没变😭😭

467 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2021-05-25 HONGGE

审稿速度:1.0 | 投稿命中率:25.0
经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。

357 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2022-08-09 121e52e6m31(暂无昵称)

审稿速度:2.0
偏重的研究方向：人工智能
经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评

519 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2022-12-22 dangjunsy 来自辽宁省

该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗

153 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2022-01-26 ms7524559905309751

投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：预期5-6分左右

361 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2020-07-29 doctor0805

审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0
经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。
另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀

163 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2023-03-05 只想躺平的小医生来自广东省

12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果

129 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2024-02-29 148ad189m02(暂无昵称) 来自北京

投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊

17 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1224997, encodeId=5395122499e59, content=第一个IF确实是15左右，高被引清一色的COVID-19论文，随着发文增加和疫情热度降低，IF会走低，2022实时IF已经只有10左右了，低于2021IF是必然, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=617, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue Jun 07 16:56:45 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237909, encodeId=7e3c123e909f2, content=请问submitted to journal一般多久啊，我都五天了还是没变😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210830/a03dcbc0f17442e3aee6d30289c4192a/7b685b39b1cd4bc7a3a662e16908e6db.jpg, createdBy=b7d05519639, createdName=ms7000001962210336, createdTime=Wed Aug 10 20:32:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968379, encodeId=c3b69683e989, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：和doctor0805，一样的经历。投lancet oncology，拒稿后推荐到ECM，免除版面费，心有不甘，再投JAMA Oncol，仍然被拒。然后接受transfer到ECM。一审25天左右，5个审稿人，二审再一个月。4月刚被SCIE收录，明年出首个IF，预计9份左右，上10有点难。期刊名字没取好，如果加个Lancet就不一样了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=357, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=254e2066521, createdName=HONGGE, createdTime=Tue May 25 15:42:46 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237492, encodeId=3132123e492e9, content=审稿速度:2.0 偏重的研究方向：人工智能 经验分享：真的是超快……大修回去几天就回来了，小修下午回去，晚上就接收了，全程2月……好评, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=519, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b582290357, createdName=121e52e6m31(暂无昵称), createdTime=Tue Aug 09 08:16:01 CST 2022, time=2022-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107090, encodeId=1751210e0907e, content=该杂志2022年中科院分区为3区，为啥啊。哪位高手能解释下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22e82567, createdName=dangjunsy, createdTime=Thu Dec 22 19:02:58 CST 2022, time=2022-12-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=1188387, encodeId=2f87118838e2f, content=投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：预期5-6分左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/lOv6uzmxsoL3HjKFWWGraianvia19uZCHERLT0Rlbr7ibHPib5yooBq8MB5lO3asBfmThneDqPJVvdBMOpuA9wufvA/0, createdBy=15b32160705, createdName=ms7524559905309751, createdTime=Wed Jan 26 19:37:03 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805030, encodeId=2f2880503089, content=审稿速度:2.0 | 投稿命中率:100.0 | 版面费用:3500.0 经验分享：本来投了篇lancet oncology，后来人家拒稿后推荐到ECM，心有不甘，再投JAMA Oncol，仍然被拒。其实我觉着完全有机会再试一试10分左右的杂志，但是这个热点过了就真过了，迅速投了ECM。6月投，7月底接收，就major revision了一次，然后连minor revision都没有就被接受了。接收后没有太多喜悦，毕竟预期10分的，本来预期是投三次，不行再转投ECM，所以才试了JAMA，最后竟然试了两次就不试其他杂志了，心太大了，浪费了一次好机会。 另外一个想吐槽的就是，版面费太贵了，两万多软妹币！恰逢国家正在改革，医院对两万以上的版面费要求作者给出必要性说明，这个真不好说呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Wed Jul 29 10:28:26 CST 2020, time=2020-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117777, encodeId=89d4211e777e0, content=12.10 submitted to journal 12.13 with editor 12.13 under review 12.13-1.8 期间under review 与 required reviewers completed交替了三次 1.10 一审意见回来，状态变成revise，4个审稿人，一共31条意见，还要求补做很多实验，之前的实验也要重新修正，编辑给了28天 2.8 申请延期5天 2.12 提交R1 2.13 with editor，当天晚上under review 2.15 二审意见回来，审稿人均无意见，编辑让按杂志社要求更改文章格式和排版，给了一周 2.17 R2 submitted 2.23 accept 从投稿到接收，全程约两个半月，特来分享投稿经历，希望给到需要的帮助，祝大家投稿都能有好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d3162266544, createdName=只想躺平的小医生, createdTime=Sun Mar 05 19:58:39 CST 2023, time=2023-03-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2190179, encodeId=cdc421901e9c2, content=投了lancet oncology编辑建议转投eclinicalmedicine，预计自己的文章在10-30之间，这种接收概率大吗？这个杂志2023预计影响因子有多少，是不是会降低啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=780c5321661, createdName=148ad189m02(暂无昵称), createdTime=Thu Feb 29 20:02:47 CST 2024, time=2024-02-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1207939, encodeId=a4ec120e9398f, content=偏重的研究方向：肿瘤 经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=512, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ff06569374, createdName=ms3000000001679338, createdTime=Fri Apr 01 20:50:03 CST 2022, time=2022-04-01, status=1, ipAttribution=)]

2022-04-01 ms3000000001679338

偏重的研究方向：肿瘤
经验分享：已接受，学之策及时IF15，吓到我了感觉不太可能

512 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务